2758 related articles for article (PubMed ID: 16368450)
1. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension.
Neutel JM; Littlejohn TW; Chrysant SG; Singh A;
Hypertens Res; 2005 Jul; 28(7):555-63. PubMed ID: 16335883
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
Zhu DL; Bays H; Gao P; Mattheus M; Voelker B; Ruilope LM
Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
Neldam S; Schumacher H; Guthrie R
Adv Ther; 2012 Apr; 29(4):327-38. PubMed ID: 22477543
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
Lacourcière Y; Neutel JM; Davidai G; Koval S
Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension.
Neldam S; Schumacher H; Kjeldsen SE; Neutel JM
Curr Med Res Opin; 2014 Sep; 30(9):1715-24. PubMed ID: 24834808
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
[TBL] [Abstract][Full Text] [Related]
8. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
Neldam S; Edwards C
Expert Opin Pharmacother; 2009 Feb; 10(3):345-52. PubMed ID: 19191674
[TBL] [Abstract][Full Text] [Related]
9. Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
Neldam S; Edwards C; Jones R;
Curr Med Res Opin; 2011 Nov; 27(11):2145-53. PubMed ID: 21955225
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of a single-pill combination of telmisartan/hydrochlorothiazide 80/25 mg in Chinese and Korean patients with moderate to severe hypertension: a subgroup analysis of a randomized, double-blind, active-controlled trial.
Zhu DL; Gao PJ; Liu SW; Jeong MH; Mattheus M; Birgit V
Chin Med J (Engl); 2013 Nov; 126(21):4072-7. PubMed ID: 24229676
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
[TBL] [Abstract][Full Text] [Related]
12. Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
Jayaram S; Lahoti S; Chandrasekharan S; Ganesan R; Muralidharan RS; Mishra AB; Sodhi SS; Rajadhyaksha GC; Jain SD; Kadam GS; Gawde A; Desai A
J Indian Med Assoc; 2004 Sep; 102(9):525-7. PubMed ID: 15887845
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
Higaki J; Komuro I; Shiki K; Ugai H; Taniguchi A; Ikeda H; Kuroki D; Nishimura S; Ogihara T
Hypertens Res; 2017 Jan; 40(1):51-60. PubMed ID: 27581533
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
17. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
McGill JB; Reilly PA
Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
[TBL] [Abstract][Full Text] [Related]
19. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
[TBL] [Abstract][Full Text] [Related]
20. Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.
Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P
J Hum Hypertens; 2006 Mar; 20(3):177-85. PubMed ID: 16306998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
